4KXB image
Deposition Date 2013-05-24
Release Date 2013-07-31
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4KXB
Keywords:
Title:
Crystal structure of human aminopeptidase A complexed with bestatin
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.25
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 64 2 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Glutamyl aminopeptidase
Gene (Uniprot):ENPEP
Chain IDs:A
Chain Length:888
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Peptide-like Molecules
PRD_900017
Primary Citation
Structural insights into central hypertension regulation by human aminopeptidase a.
J.Biol.Chem. 288 25638 25645 (2013)
PMID: 23888046 DOI: 10.1074/jbc.M113.494955

Abstact

Hypertension is regulated through both the central and systemic renin-angiotensin systems. In the central renin-angiotensin system, zinc-dependent aminopeptidase A (APA) up-regulates blood pressure by specifically cleaving the N-terminal aspartate, but not the adjacent arginine, from angiotensin II, a process facilitated by calcium. Here, we determined the crystal structures of human APA and its complexes with different ligands and identified a calcium-binding site in the S1 pocket of APA. Without calcium, the S1 pocket can bind both acidic and basic residues through formation of salt bridges with the charged side chains. In the presence of calcium, the binding of acidic residues is enhanced as they ligate the cation, whereas the binding of basic residues is no longer favorable due to charge repulsion. Of the peptidomimetic inhibitors of APA, amastatin has higher potency than bestatin by fitting better in the S1 pocket and interacting additionally with the S3' subsite. These results explain the calcium-modulated substrate specificity of APA in central hypertension regulation and can guide the design and development of brain-targeting antihypertensive APA inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures